Optic nerve involvement in experimental autoimmune encephalomyelitis to homologous spinal cord homogenate immunization in the dark agouti rat

J Neuroimmunol. 2018 Dec 15:325:1-9. doi: 10.1016/j.jneuroim.2018.09.009. Epub 2018 Sep 25.

Abstract

Dark-Agouti rats were immunized with spinal cord homogenate to develop Experimental Autoimmune Encephalomyelitis, a model of multiple sclerosis. We assessed motor signs and recorded VEPs for five or eight weeks with epidural or epidermal electrodes, respectively, with final histopathology of optic nerves (ONs). Injected rats exhibited motor deficits a week after immunization. VEP delays arose from the 2nd to the 5th week, when a recovery occurred in epidermal-recorded rats. ON damage appeared in epidural-, but not in epidermal-recorded rats, probably due to a remyelination process. VEP could be exploited as neurophysiological marker to test novel treatments against neurodegeneration involving ONs.

Keywords: Experimental autoimmune encephalomyelitis; Optic neuritis; Spinal cord homogenate; Visual evoked potentials.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Electrodes, Implanted
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Evoked Potentials, Visual / physiology*
  • Female
  • Immunization / adverse effects
  • Optic Nerve / immunology*
  • Optic Nerve / pathology
  • Optic Neuritis / immunology
  • Optic Neuritis / pathology
  • Rats
  • Spinal Cord / immunology*
  • Spinal Cord / pathology